vs
Mayville Engineering Company, Inc.（MEC）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Mayville Engineering Company, Inc.的1.6倍（$219.9M vs $134.3M），Orthofix Medical Inc.净利率更高（-1.0% vs -3.2%，领先2.2%），Mayville Engineering Company, Inc.同比增速更快（10.7% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $10.2M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -8.8%）
Mayville Engineering Company（MEC）是总部位于美国的领先金属零部件、装配组件及定制工程解决方案供应商，主要服务农业、建筑、商用运输、国防、动力运动等领域的原始设备制造商客户，提供从原型开发到大规模量产的全流程服务。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MEC vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.6倍
$134.3M
营收增速更快
MEC
高出8.7%
2.0%
净利率更高
OFIX
高出2.2%
-3.2%
自由现金流更多
OFIX
多$6.7M
$10.2M
两年增速更快
OFIX
近两年复合增速
-8.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $134.3M | $219.9M |
| 净利润 | $-4.4M | $-2.2M |
| 毛利率 | 6.8% | 71.1% |
| 营业利润率 | -4.1% | 0.2% |
| 净利率 | -3.2% | -1.0% |
| 营收同比 | 10.7% | 2.0% |
| 净利润同比 | -127.3% | 92.4% |
| 每股收益（稀释后） | $-0.22 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MECOFIX
| Q4 25 | $134.3M | $219.9M | ||
| Q3 25 | $144.3M | $205.6M | ||
| Q2 25 | $132.3M | $203.1M | ||
| Q1 25 | $135.6M | $193.6M | ||
| Q4 24 | $121.3M | $215.7M | ||
| Q3 24 | $135.4M | $196.6M | ||
| Q2 24 | $163.6M | $198.6M | ||
| Q1 24 | $161.3M | $188.6M |
净利润MECOFIX
| Q4 25 | $-4.4M | $-2.2M | ||
| Q3 25 | $-2.7M | $-22.8M | ||
| Q2 25 | $-1.1M | $-14.1M | ||
| Q1 25 | $20.0K | $-53.1M | ||
| Q4 24 | $16.0M | $-29.1M | ||
| Q3 24 | $3.0M | $-27.4M | ||
| Q2 24 | $3.8M | $-33.4M | ||
| Q1 24 | $3.2M | $-36.0M |
毛利率MECOFIX
| Q4 25 | 6.8% | 71.1% | ||
| Q3 25 | 11.0% | 72.2% | ||
| Q2 25 | 10.3% | 68.7% | ||
| Q1 25 | 11.3% | 62.8% | ||
| Q4 24 | 8.9% | 69.0% | ||
| Q3 24 | 12.6% | 68.7% | ||
| Q2 24 | 13.6% | 67.8% | ||
| Q1 24 | 13.0% | 67.5% |
营业利润率MECOFIX
| Q4 25 | -4.1% | 0.2% | ||
| Q3 25 | 0.0% | -8.3% | ||
| Q2 25 | 0.1% | -7.9% | ||
| Q1 25 | 1.2% | -25.2% | ||
| Q4 24 | 19.0% | -5.3% | ||
| Q3 24 | 4.2% | -9.6% | ||
| Q2 24 | 5.0% | -12.5% | ||
| Q1 24 | 4.7% | -15.6% |
净利率MECOFIX
| Q4 25 | -3.2% | -1.0% | ||
| Q3 25 | -1.9% | -11.1% | ||
| Q2 25 | -0.8% | -6.9% | ||
| Q1 25 | 0.0% | -27.4% | ||
| Q4 24 | 13.2% | -13.5% | ||
| Q3 24 | 2.2% | -13.9% | ||
| Q2 24 | 2.3% | -16.8% | ||
| Q1 24 | 2.0% | -19.1% |
每股收益（稀释后）MECOFIX
| Q4 25 | $-0.22 | $-0.05 | ||
| Q3 25 | $-0.13 | $-0.57 | ||
| Q2 25 | $-0.05 | $-0.36 | ||
| Q1 25 | $0.00 | $-1.35 | ||
| Q4 24 | $0.76 | $-0.76 | ||
| Q3 24 | $0.14 | $-0.71 | ||
| Q2 24 | $0.18 | $-0.88 | ||
| Q1 24 | $0.16 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.5M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $240.7M | $450.0M |
| 总资产 | $563.6M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MECOFIX
| Q4 25 | $1.5M | $82.0M | ||
| Q3 25 | $1.2M | $62.9M | ||
| Q2 25 | $206.0K | $65.6M | ||
| Q1 25 | $183.0K | $58.0M | ||
| Q4 24 | $206.0K | $83.2M | ||
| Q3 24 | $178.0K | $30.1M | ||
| Q2 24 | $314.0K | $26.4M | ||
| Q1 24 | $314.0K | $27.0M |
总债务MECOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益MECOFIX
| Q4 25 | $240.7M | $450.0M | ||
| Q3 25 | $244.8M | $442.5M | ||
| Q2 25 | $246.8M | $458.3M | ||
| Q1 25 | $250.0M | $458.3M | ||
| Q4 24 | $251.8M | $503.1M | ||
| Q3 24 | $238.4M | $525.9M | ||
| Q2 24 | $238.1M | $546.0M | ||
| Q1 24 | $234.0M | $570.3M |
总资产MECOFIX
| Q4 25 | $563.6M | $850.6M | ||
| Q3 25 | $585.6M | $832.6M | ||
| Q2 25 | $433.7M | $837.2M | ||
| Q1 25 | $447.7M | $823.1M | ||
| Q4 24 | $445.6M | $893.3M | ||
| Q3 24 | $466.0M | $867.9M | ||
| Q2 24 | $488.2M | $882.0M | ||
| Q1 24 | $499.9M | $906.0M |
负债/权益比MECOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $10.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 7.6% | 7.6% |
| 资本支出强度资本支出/营收 | 2.4% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $26.9M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MECOFIX
| Q4 25 | $13.4M | $27.7M | ||
| Q3 25 | $1.9M | $12.4M | ||
| Q2 25 | $15.0M | $11.6M | ||
| Q1 25 | $8.3M | $-18.4M | ||
| Q4 24 | $38.0M | $23.7M | ||
| Q3 24 | $17.9M | $11.7M | ||
| Q2 24 | $23.3M | $9.0M | ||
| Q1 24 | $10.6M | $-18.6M |
自由现金流MECOFIX
| Q4 25 | $10.2M | $16.8M | ||
| Q3 25 | $-1.1M | $2.5M | ||
| Q2 25 | $12.5M | $4.5M | ||
| Q1 25 | $5.4M | $-25.1M | ||
| Q4 24 | $35.6M | $15.2M | ||
| Q3 24 | $15.1M | $6.3M | ||
| Q2 24 | $19.2M | $-360.0K | ||
| Q1 24 | $7.8M | $-29.1M |
自由现金流率MECOFIX
| Q4 25 | 7.6% | 7.6% | ||
| Q3 25 | -0.8% | 1.2% | ||
| Q2 25 | 9.5% | 2.2% | ||
| Q1 25 | 4.0% | -13.0% | ||
| Q4 24 | 29.4% | 7.0% | ||
| Q3 24 | 11.1% | 3.2% | ||
| Q2 24 | 11.7% | -0.2% | ||
| Q1 24 | 4.9% | -15.4% |
资本支出强度MECOFIX
| Q4 25 | 2.4% | 4.9% | ||
| Q3 25 | 2.1% | 4.8% | ||
| Q2 25 | 1.8% | 3.5% | ||
| Q1 25 | 2.2% | 3.5% | ||
| Q4 24 | 1.9% | 4.0% | ||
| Q3 24 | 2.1% | 2.7% | ||
| Q2 24 | 2.5% | 4.7% | ||
| Q1 24 | 1.7% | 5.6% |
现金转化率MECOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 416.65× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 6.03× | — | ||
| Q2 24 | 6.15× | — | ||
| Q1 24 | 3.28× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MEC
| Fabrication | $72.2M | 54% |
| Construction And Access | $19.2M | 14% |
| Tubes | $16.2M | 12% |
| Other Market | $11.9M | 9% |
| Agriculture | $7.7M | 6% |
| Military | $6.7M | 5% |
| Outdoor Sports | $1.7M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
